365 related articles for article (PubMed ID: 26190650)
1. Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.
Xia JY; Holland WL; Kusminski CM; Sun K; Sharma AX; Pearson MJ; Sifuentes AJ; McDonald JG; Gordillo R; Scherer PE
Cell Metab; 2015 Aug; 22(2):266-278. PubMed ID: 26190650
[TBL] [Abstract][Full Text] [Related]
2. Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis.
Holland WL; Xia JY; Johnson JA; Sun K; Pearson MJ; Sharma AX; Quittner-Strom E; Tippetts TS; Gordillo R; Scherer PE
Mol Metab; 2017 Mar; 6(3):267-275. PubMed ID: 28271033
[TBL] [Abstract][Full Text] [Related]
3. Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes.
Chaurasia B; Ying L; Talbot CL; Maschek JA; Cox J; Schuchman EH; Hirabayashi Y; Holland WL; Summers SA
Mol Metab; 2021 Mar; 45():101145. PubMed ID: 33352310
[TBL] [Abstract][Full Text] [Related]
4. The ART of Lowering Ceramides.
Summers SA
Cell Metab; 2015 Aug; 22(2):195-6. PubMed ID: 26244926
[TBL] [Abstract][Full Text] [Related]
5. Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice.
Correnti J; Lin C; Brettschneider J; Kuriakose A; Jeon S; Scorletti E; Oranu A; McIver-Jenkins D; Kaneza I; Buyco D; Saiman Y; Furth EE; Argemi J; Bataller R; Holland WL; Carr RM
J Lipid Res; 2020 Jul; 61(7):983-994. PubMed ID: 32398264
[TBL] [Abstract][Full Text] [Related]
6. Targeting a ceramide double bond improves insulin resistance and hepatic steatosis.
Chaurasia B; Tippetts TS; Mayoral Monibas R; Liu J; Li Y; Wang L; Wilkerson JL; Sweeney CR; Pereira RF; Sumida DH; Maschek JA; Cox JE; Kaddai V; Lancaster GI; Siddique MM; Poss A; Pearson M; Satapati S; Zhou H; McLaren DG; Previs SF; Chen Y; Qian Y; Petrov A; Wu M; Shen X; Yao J; Nunes CN; Howard AD; Wang L; Erion MD; Rutter J; Holland WL; Kelley DE; Summers SA
Science; 2019 Jul; 365(6451):386-392. PubMed ID: 31273070
[TBL] [Abstract][Full Text] [Related]
7. Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice.
Seo KH; Bartley GE; Tam C; Kim HS; Kim DH; Chon JW; Kim H; Yokoyama W
PLoS One; 2016; 11(12):e0167680. PubMed ID: 27977712
[TBL] [Abstract][Full Text] [Related]
8. Consumption of a high-fat diet rapidly exacerbates the development of fatty liver disease that occurs with chronically elevated glucocorticoids.
D'souza AM; Beaudry JL; Szigiato AA; Trumble SJ; Snook LA; Bonen A; Giacca A; Riddell MC
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G850-63. PubMed ID: 22268100
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
11. Mesenteric Fat Lipolysis Mediates Obesity-Associated Hepatic Steatosis and Insulin Resistance.
Wueest S; Item F; Lucchini FC; Challa TD; Müller W; Blüher M; Konrad D
Diabetes; 2016 Jan; 65(1):140-8. PubMed ID: 26384383
[TBL] [Abstract][Full Text] [Related]
12. Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.
Bell-Anderson KS; Aouad L; Williams H; Sanz FR; Phuyal J; Larter CZ; Farrell GC; Caterson ID
Int J Obes (Lond); 2011 Dec; 35(12):1539-48. PubMed ID: 21386801
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C ε in mice.
Stout MB; Liu LF; Belury MA
Mol Nutr Food Res; 2011 Jul; 55(7):1010-7. PubMed ID: 21480517
[TBL] [Abstract][Full Text] [Related]
14. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
15. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.
Ter Horst KW; Gilijamse PW; Versteeg RI; Ackermans MT; Nederveen AJ; la Fleur SE; Romijn JA; Nieuwdorp M; Zhang D; Samuel VT; Vatner DF; Petersen KF; Shulman GI; Serlie MJ
Cell Rep; 2017 Jun; 19(10):1997-2004. PubMed ID: 28591572
[TBL] [Abstract][Full Text] [Related]
17. Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.
Peyrou M; Bourgoin L; Poher AL; Altirriba J; Maeder C; Caillon A; Fournier M; Montet X; Rohner-Jeanrenaud F; Foti M
J Hepatol; 2015 Feb; 62(2):421-9. PubMed ID: 25234947
[TBL] [Abstract][Full Text] [Related]
18. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
20. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
Darkhal P; Gao M; Ma Y; Liu D
Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
